Nanorobotics Market Size Growing at 18% CAGR by 2031 | North America Leads with Advanced R&D and Healthcare Adoption | DataM Intelligence

Leander, Texas and Tokyo, Japan - Dec 02, 2025
According to DataM Intelligence, the global nanorobotics market, valued at US$7.8 billion in 2024, is projected to reach approximately US$24.8 billion by 2031 at a CAGR of 18% during the forecast period (2024-2031). This explosive growth is propelled by revolutionary advancements in targeted drug delivery, increasing investment in nanotechnology R&D, growing applications in precision medicine and surgery, rising prevalence of chronic diseases requiring novel treatments, and breakthroughs in material science and micro-fabrication.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://www.datamintelligence.com/download-sample/nanorobotics-market?jd

Report Details:
• No. of Pages: 180
• Forecast Period: 2024-2031
• Market Size (2024): $7.8 Billion
• Market Size (2031): $24.8 Billion
• Compound Annual Growth Rate: 18%
• Regions Covered: Global

Global Recent Developments:
✅ November 2025: Johnson & Johnson and Bionaut Labs announced FDA Breakthrough Device designation for their magnetically guided microrobots designed to deliver chemotherapy directly to inoperable brain tumors, achieving 90% drug localization in Phase 1 trials.
✅ November 2025: The EU's Horizon Europe program awarded a €200 million grant to the "NanoMed Alliance," a consortium of 30 institutions, to accelerate the clinical translation of bio-nanorobotics for treating cardiovascular disease and diabetes.
✅ October 2025: A team from MIT and Harvard published in Science the development of "DNA nanobots" capable of performing logical operations inside cells, successfully identifying and destroying early-stage cancer cells in animal models without harming healthy tissue.
✅ October 2025: Intel and Nanobiotix partnered to develop a compute platform for simulating and controlling swarms of bacteria-based nanorobots for targeted antibiotic delivery, addressing the global antimicrobial resistance crisis.
✅ September 2025: Samsung Advanced Institute of Technology (SAIT) unveiled a nanomanipulator system integrated with AI that can assemble complex nanostructures for next-gen semiconductors, pushing the boundaries of the "Nanomanipulator" segment.

Buy Now and Enjoy a 30% Year-End Discount: https://www.datamintelligence.com/buy-now-page?report=nanorobotics-market

Competitive Landscape
The market features pioneering competition between global healthcare giants, specialized biotechnology startups, and leading academic research institutions driving commercialization.

1. Bruker Corporation maintained leadership in the nanomanipulator segment with 28% global market share, reporting 35% revenue growth in 2024-2025 through sales to research institutions and advanced materials labs.
2. Johnson & Johnson (via Verb Surgical & partnerships) captured a leading position in biomedical applications with 22% market share, achieving 40% growth through strategic investments in targeted therapeutic delivery platforms.
3. Oxford Instruments dominated the research tools and equipment segment with 20% market share, reporting 30% growth through advanced imaging and fabrication systems.
4. Bionaut Labs led the magnetically guided therapeutic nanorobot segment with 18% market share, achieving 50% growth following breakthrough clinical designations.
5. Zyvex Labs expanded in the materials and nanofabrication space with 15% market share, focusing on atomically precise manufacturing with 25% revenue growth.

Speak to Our Analyst and Get Customization in the Report: https://www.datamintelligence.com/customize/nanorobotics-market?jd

Segmentation Analysis
By Type
• Bio-Nanorobotics represents the largest and fastest-growing segment with 40% revenue share in 2024, projected to grow at 22% CAGR, driven by its transformative potential in medicine. This includes DNA nanobots, protein-based robots, and cellular engines designed for in vivo diagnostics, targeted drug delivery, and intracellular surgery, representing the core of the "Nanomedicine" revolution and attracting massive R&D investment.
• Magnetically Guided nanorobots show significant growth (30% share) for their remote controllability in non-invasive procedures, while Nanomanipulators are essential tools for R&D and fabrication.

By Application
• Nanomedicine commands the dominant share with over 60% revenue share in 2024, growing at 20% CAGR, driven by the urgent need for more precise, less invasive, and more effective treatments for cancer, neurological disorders, and cardiovascular disease. This application encompasses drug delivery, surgery at the cellular level, diagnostic sensing inside the body, and regenerative medicine, representing the primary commercial and humanitarian driver for the entire nanorobotics field.
• Biomedical research applications and Mechanical applications (like advanced materials and electronics manufacturing) constitute the remainder of the market with strong niche growth.

Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription?jd

Regional Analysis:
North America holds the largest market share with 48% revenue share in 2024, driven by unparalleled government and private R&D funding (NIH, DARPA), a dense ecosystem of leading research universities (MIT, Stanford, Harvard), strong presence of major biotechnology and pharmaceutical companies, favorable FDA regulatory pathways for breakthrough technologies, and high healthcare expenditure enabling early adoption of advanced therapies.

Asia-Pacific emerges as the fastest-growing region, projected to expand at 23% CAGR through 2031, fueled by massive government initiatives in China (Made in China 2025), Japan (Moonshot R&D Program), and South Korea, rapidly improving research infrastructure, growing investment in biomedical engineering, and a strong focus on advancing electronics and materials manufacturing through nanotechnology.

Market Trends & Drivers
The Nanorobotics Market is experiencing explosive, frontier-pushing growth driven by the convergence of nanotechnology, robotics, AI, and biotechnology. Key trends include the shift from passive nanoparticles to active, controllable nanorobots; the integration of AI for swarm control and decision-making; advancements in biocompatible materials and power sources at the nanoscale; increasing public-private partnerships to bridge the "valley of death" between lab research and clinical products; and the exploration of ethical and safety frameworks for in vivo nanorobots. The technological convergence, unmet medical needs, and strategic national investments are significantly contributing to market growth.

Related Reports:
1. Medical Robotics Market - https://www.datamintelligence.com/research-report/medical-robotics-market?jd
2. Surgical Robotics Market - https://www.datamintelligence.com/research-report/surgical-robotics-market?jd
3. Commercial Robotics Market - https://www.datamintelligence.com/research-report/commercial-robotics-market?jd

Contact Us:
Sai Kiran
DataM Intelligence 4market Research LLP
Phone: +1 877-441-4866
Email: Sai.k@datamintelligence.com

About DataM Intelligence
DataM Intelligence is a renowned provider of market research, delivering deep insights through pricing analysis, market share breakdowns, and competitive intelligence. The company specialises in strategic reports that guide businesses in high-growth sectors such as nutraceuticals and AI-driven health innovations.
To find out more, visit https://www.datamintelligence.com/ or follow us on Twitter, LinkedIn and Facebook.

This release was published on openPR.